BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29332411)

  • 1. β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway.
    Tian T; Li CL; Fu X; Wang SH; Lu J; Guo H; Yao Y; Nan KJ; Yang YJ
    J Int Med Res; 2018 Apr; 46(4):1311-1325. PubMed ID: 29332411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway.
    Guo D; Zhang D; Ren M; Lu G; Zhang X; He S; Li Y
    FASEB J; 2020 Aug; 34(8):10668-10681. PubMed ID: 32567740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of matrix stiffness relating integrin β1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts.
    Wang C; Jiang X; Huang B; Zhou W; Cui X; Zheng C; Liu F; Bi J; Zhang Y; Luo H; Yuan L; Yang J; Yu Y
    BMC Cancer; 2021 Nov; 21(1):1276. PubMed ID: 34823500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma.
    Li Y; Ren Z; Wang Y; Dang YZ; Meng BX; Wang GD; Zhang J; Wu J; Wen N
    Exp Cell Res; 2018 Sep; 370(2):373-382. PubMed ID: 29966664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling.
    Wu J; Li Y; Dang YZ; Gao HX; Jiang JL; Chen ZN
    Mol Cancer Ther; 2015 Feb; 14(2):553-63. PubMed ID: 25534361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer.
    Chitcholtan K; Sykes PH; Evans JJ
    J Transl Med; 2012 Mar; 10():38. PubMed ID: 22394685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.
    You Y; Zheng Q; Dong Y; Xie X; Wang Y; Wu S; Zhang L; Wang Y; Xue T; Wang Z; Chen R; Wang Y; Cui J; Ren Z
    Oncotarget; 2016 May; 7(22):32221-31. PubMed ID: 27050147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture.
    Cui J; Nan KJ; Tian T; Guo YH; Zhao N; Wang L
    World J Gastroenterol; 2007 Nov; 13(41):5432-9. PubMed ID: 17907285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt/NF-kappaB signaling pathway in colorectal carcinomas.
    Chen Y; Wang Z; Chang P; Xiang L; Pan F; Li J; Jiang J; Zou L; Yang L; Bian Z; Liang H
    Int J Cancer; 2010 Jul; 127(1):195-206. PubMed ID: 19904749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
    Liu T; Wu X; Li Y; Lu W; Zheng F; Zhang C; Long Q; Qiu H; Li Y; Ge Q; Chen M; Yu X; Chen W; Zhang H; Huang W; Luo M; Deng W; Li L
    Cell Physiol Biochem; 2018; 46(4):1365-1380. PubMed ID: 29689552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.
    Liu C; Qu L; Zhao C; Shou C
    J Exp Clin Cancer Res; 2018 Jun; 37(1):117. PubMed ID: 29903032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
    J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cordycepin suppresses integrin/FAK signaling and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yao WL; Ko BS; Liu TA; Liang SM; Liu CC; Lu YJ; Tzean SS; Shen TL; Liou JY
    Anticancer Agents Med Chem; 2014 Jan; 14(1):29-34. PubMed ID: 23855336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rAj-Tspin, a novel recombinant peptide from Apostichopus japonicus, suppresses the proliferation, migration, and invasion of BEL-7402 cells via a mechanism associated with the ITGB1-FAK-AKT pathway.
    Yu P; Wu R; Zhou Z; Zhang X; Wang R; Wang X; Lin S; Wang J; Lv L
    Invest New Drugs; 2021 Apr; 39(2):377-385. PubMed ID: 32989643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular network.
    Zhang L; Zhao D; Wang Y; Zhang W; Zhang J; Fan J; Zhan Q; Chen J
    Mol Carcinog; 2021 Feb; 60(2):113-124. PubMed ID: 33283357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth.
    Tancioni I; Miller NL; Uryu S; Lawson C; Jean C; Chen XL; Kleinschmidt EG; Schlaepfer DD
    Breast Cancer Res; 2015 Mar; 17():47. PubMed ID: 25880415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limonin provokes hepatocellular carcinoma cells with stemness entry into cycle via activating PI3K/Akt signaling.
    Tang Z; Tang Y; Li L; Liu T; Yang J
    Biomed Pharmacother; 2019 Sep; 117():109051. PubMed ID: 31177062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cell adhesion signal molecules in hepatocellular carcinoma cell apoptosis.
    Su JM; Wang LY; Liang YL; Zha XL
    World J Gastroenterol; 2005 Aug; 11(30):4667-73. PubMed ID: 16094707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
    Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.